Triple
T5651882
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Norwegian Institute of Public Health |
E124529
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object |
Centre for Laboratory-based Surveillance
The Centre for Laboratory-based Surveillance is a specialized unit within Norway’s public health system that monitors infectious diseases and other health threats through the analysis and coordination of laboratory data.
|
E535420
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Centre for Laboratory-based Surveillance | Statement: [Norwegian Institute of Public Health, hasPart, Centre for Laboratory-based Surveillance]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Centre for Laboratory-based Surveillance Context triple: [Norwegian Institute of Public Health, hasPart, Centre for Laboratory-based Surveillance]
-
A.
Office of Surveillance and Epidemiology
The Office of Surveillance and Epidemiology is a U.S. FDA office responsible for monitoring the safety and effectiveness of marketed drugs and therapeutic biologics through post-market surveillance and risk assessment.
-
B.
Center for Communicable Disease Dynamics
The Center for Communicable Disease Dynamics is a research center focused on understanding, modeling, and controlling infectious disease transmission and outbreaks.
-
C.
Bureau of Infectious Disease and Laboratory Sciences
The Bureau of Infectious Disease and Laboratory Sciences is a division of Massachusetts’ state public health system that oversees infectious disease surveillance, prevention, and diagnostic laboratory services.
-
D.
Centers for Disease Control and Prevention reference laboratory partner
The Wadsworth Center is a major public health laboratory and research institution that serves as New York State’s primary reference lab and collaborates closely with federal agencies on disease surveillance, diagnostics, and outbreak response.
-
E.
Institute of Infection and Immunity
The Institute of Infection and Immunity is a Canadian health research institute that focuses on advancing knowledge, prevention, and treatment of infectious diseases and disorders of the immune system.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Centre for Laboratory-based Surveillance Triple: [Norwegian Institute of Public Health, hasPart, Centre for Laboratory-based Surveillance]
Generated description
The Centre for Laboratory-based Surveillance is a specialized unit within Norway’s public health system that monitors infectious diseases and other health threats through the analysis and coordination of laboratory data.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Centre for Laboratory-based Surveillance Target entity description: The Centre for Laboratory-based Surveillance is a specialized unit within Norway’s public health system that monitors infectious diseases and other health threats through the analysis and coordination of laboratory data.
-
A.
Office of Surveillance and Epidemiology
The Office of Surveillance and Epidemiology is a U.S. FDA office responsible for monitoring the safety and effectiveness of marketed drugs and therapeutic biologics through post-market surveillance and risk assessment.
-
B.
Center for Communicable Disease Dynamics
The Center for Communicable Disease Dynamics is a research center focused on understanding, modeling, and controlling infectious disease transmission and outbreaks.
-
C.
Bureau of Infectious Disease and Laboratory Sciences
The Bureau of Infectious Disease and Laboratory Sciences is a division of Massachusetts’ state public health system that oversees infectious disease surveillance, prevention, and diagnostic laboratory services.
-
D.
Centers for Disease Control and Prevention reference laboratory partner
The Wadsworth Center is a major public health laboratory and research institution that serves as New York State’s primary reference lab and collaborates closely with federal agencies on disease surveillance, diagnostics, and outbreak response.
-
E.
Institute of Infection and Immunity
The Institute of Infection and Immunity is a Canadian health research institute that focuses on advancing knowledge, prevention, and treatment of infectious diseases and disorders of the immune system.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00825df388190a58742fa9b1aa33d |
completed | March 22, 2026, 3:17 p.m. |
| NER | Named-entity recognition | batch_69c022d6af9481909eaeead2a39525ce |
completed | March 22, 2026, 5:11 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c04d941ea4819084bab644d6cc2153 |
completed | March 22, 2026, 8:14 p.m. |
| NEDg | Description generation | batch_69c04edcc0208190bd69b5cce89596f9 |
completed | March 22, 2026, 8:19 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69c04ff814b88190ad01844ae2629c6e |
completed | March 22, 2026, 8:24 p.m. |
Created at: March 22, 2026, 3:42 p.m.